{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"SIGA Technologies Inc."},"Symbol":{"label":"Symbol","value":"SIGA"},"Address":{"label":"Address","value":"31 EAST 62ND STREET, NEW YORK, New York, 10065, United States"},"Phone":{"label":"Phone","value":"+1 212 672-9100"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox."},"CompanyUrl":{"label":"Company Url","value":"https://www.siga.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Dennis E. Hruby","title":"Chief Scientific Officer & Executive VP"},{"name":"Diem Nguyen","title":"Chief Executive Officer & Director"},{"name":"Herb Vloedman","title":"Chief Information Officer"},{"name":"Tove C. Bolken","title":"Senior VP-Operations & Chief Supply Chain Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}